About NuvoAir
NuvoAir is a company based in Stockholm (Sweden) founded in 2015 by Lorenzo Consoli. NuvoAir has raised $28.1 million across 4 funding rounds from investors including Hikma Ventures, dRx Capital and Kaya. NuvoAir offers products and services including Air Next Spirometer, Pulse Oximeter, and NuvoAir App. NuvoAir operates in a competitive market with competitors including QuidelOrtho, BioSerenity, ProciseDx, Neurosynaptic and MedTel Healthcare, among others.
- Headquarter Stockholm, Sweden
- Founders Lorenzo Consoli
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nuvoair Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$28.1 M (USD)
in 4 rounds
-
Latest Funding Round
$11 M (USD), Series A
Jan 19, 2022
-
Investors
Hikma Ventures
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NuvoAir
NuvoAir offers a comprehensive portfolio of products and services, including Air Next Spirometer, Pulse Oximeter, and NuvoAir App.
Measures lung capacity for home monitoring of respiratory conditions.
Tracks oxygen levels and heart rate for chronic health management.
Facilitates virtual appointments and data sharing for patient care.
People of NuvoAir
Unlock access to complete
Funding Insights of NuvoAir
NuvoAir has successfully raised a total of $28.1M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $11 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NuvoAir
NuvoAir has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Hikma Ventures, dRx Capital and Kaya.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Hikma Ventures is focused on digital health investments.
|
Locked | Locked | Locked | |
|
Early-stage investments in US Tech and Life Sciences are targeted.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on pre-seed and series A investments
|
Locked | Locked | Locked |
Investor details for NuvoAir
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NuvoAir
Investment portfolio details for NuvoAir
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NuvoAir
Detailed financials for NuvoAir
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nuvoair Comparisons
Peer comparison for NuvoAir
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NuvoAir
NuvoAir operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as QuidelOrtho, BioSerenity, ProciseDx, Neurosynaptic and MedTel Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of healthcare information services
|
|
| Locked | Locked | Locked |
Provider of smart healthcare solutions for sleep and EEG lab management
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for immunoassay tests are provided to clinicians.
|
|
| Locked | Locked | Locked |
ICT-based products and solutions are developed for healthcare.
|
|
| Locked | Locked | Locked |
Remote patient monitoring software is developed for healthcare providers.
|
Detailed competitors of NuvoAir
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nuvoair
Complete news archive for NuvoAir
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NuvoAir
NuvoAir was founded in 2015 and raised its 1st funding round 2 years after it was founded.
NuvoAir is headquartered in Stockholm, Sweden.
Lorenzo Consoli is the current CEO of NuvoAir. They have also founded this company.
NuvoAir is a funded company, having raised a total of $28.1M across 4 funding rounds to date.
NuvoAir was founded in 2015 in Stockholm, Sweden, within the health technology sector. Clinical decision support tools for monitoring and diagnosing respiratory diseases are offered by the company. The Air Next spirometer is utilized to deliver insights on cystic fibrosis through patient inhalation data collected via smart inhalers and sensor-based devices. The Air MD software application is employed to examine patient medical data longitudinally, aiding clinical decision-making processes.
NuvoAir's top competitors include MedTel Healthcare, QuidelOrtho and Neurosynaptic.
NuvoAir offers Air Next Spirometer, Pulse Oximeter, and NuvoAir App.
NuvoAir has 7 investors. Key investors include Hikma Ventures, dRx Capital, Kaya, Amino Collective, and Spiltan Invest.